CLINICAL TRIALS PROFILE FOR IBSRELA
✉ Email this page to a colleague
All Clinical Trials for IBSRELA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05905926 ↗ | Tenapanor for the Treatment of Pediatric Patients With Irritable Bowel Syndrome With Constipation (IBS-C) | Enrolling by invitation | Ardelyx | Phase 3 | 2023-02-17 | Open-label long-term safety study of tenapanor in pediatric patients with IBS-C. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for IBSRELA
Condition Name
Clinical Trial Locations for IBSRELA
Trials by Country
Clinical Trial Progress for IBSRELA
Clinical Trial Phase
Clinical Trial Sponsors for IBSRELA
Sponsor Name